0001209191-19-050588.txt : 20190924
0001209191-19-050588.hdr.sgml : 20190924
20190924181415
ACCESSION NUMBER: 0001209191-19-050588
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190920
FILED AS OF DATE: 20190924
DATE AS OF CHANGE: 20190924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PIMSTONE SIMON N.
CENTRAL INDEX KEY: 0001620084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 191111688
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G4W8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-20
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001620084
PIMSTONE SIMON N.
200 - 3650 GILMORE WAY
BURNABY
A1
BRITISH COLUMBIA, CANADA
1
1
0
0
CEO
Common Shares
2019-09-20
4
S
0
10395
9.51
D
258122
D
Common Shares
16460
I
Spouse
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
/s/ Sherry Aulin, Attorney-in-fact
2019-09-24